Cargando…
Biological Therapies for the Management of Enteric Disease: Considerations for the Clinician
Several biologic therapies have been approved for enteric diseases. We evaluate each biologic’s role based on their mechanism of action in treating these conditions. This review examines data on efficacy and safety, as well as considerations for using these therapies in clinical practice in inflamma...
Autores principales: | Saleh, Adam, Ansari, Usman, Abughazaleh, Shaadi, Glassner, Kerri, Abraham, Bincy P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9211072/ https://www.ncbi.nlm.nih.gov/pubmed/35747234 http://dx.doi.org/10.2147/BTT.S335697 |
Ejemplares similares
-
Patient Attitudes and Barriers to Endoscopy During the COVID-19 Pandemic
por: Ergun, Gulchin A., et al.
Publicado: (2023) -
Risk Factors for and Frequency of CT Scans, Steroid Use, and Repeat Visits in Inflammatory Bowel Disease Patients Seen at a Single-Center Emergency Department: A Retrospective Cohort Study
por: Euers, Lindsay, et al.
Publicado: (2021) -
Clinical Evaluation of Upadacitinib in the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis (UC): Patient Selection and Reported Outcomes
por: Irani, Malcolm, et al.
Publicado: (2023) -
Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol
por: Abughazaleh, Shaadi, et al.
Publicado: (2020) -
Autoimmune liver disease and the enteric microbiome
por: Glassner, Kerri, et al.
Publicado: (2018)